Written by Meera Boyapati
Introduction
Americans spend nearly twice the amount on healthcare per person as citizens of other high-income countries do, yet they still face surprise bills, rising premiums, and insurance plans that often fail to cover costs of patients’ greatest needs. According to Yale Insights, the United States spends over 18.0% of its GDP on healthcare, more than any other nation; yet, millions struggle to access basic services (Cooper, 2016). The paradox of paying more for worse outcomes has sparked a national question: How did the world’s wealthiest country (by total GDP) end up with the world’s most expensive healthcare system? The answer lies in a century of policy choices, a fragmented insurance structure, and economic incentives that promote complexity over efficiency.
Historical Context: Then to Now
To understand today’s healthcare costs, one must start with the system’s origins. In the early 20th century, U.S. medical spending rose quickly as hospitals became modernized. The Committee on the Costs of Medical Care (CCMC), formed in 1927, found that many Americans could not afford necessary care and recommended the expansion of health insurance (Committee on the Costs of Medical Care, 1932). However, their recommendations clashed with political views at the time. Many policymakers and medical groups opposed “socialized medicine,” fearing government interference in doctors’ independence and private markets. Due to pressure from the AMA and a political climate favoring limited government, major reforms were blocked, leaving millions without affordable coverage.
Everything changed during World War II, when wage controls aimed to control inflation prevented employers from raising pay. Instead, firms began offering health benefits to attract workers. The federal government allowed this loophole and even made it tax-advantaged. Suddenly, employer-based insurance became the backbone of U.S. healthcare, not because it was the most efficient system, but because it was the easiest political compromise: it satisfied employers, who avoided government mandates, and workers, who gained medical access without a national program.
This created the healthcare system today: a fragmented multi-payer system where private insurance, employer-provided plans, Medicare, Medicaid, and other programs operate simultaneously. As Papanicolas et al. (2018) explain, this fragmentation introduced layers of billing complexity and administrative burden unprecedented anywhere else. Studies from the Commonwealth Fund confirm that this patchwork structure is a core driver of the nation’s high costs, with administrative costs accounting for approximately 15% of excess U.S. spending compared to other countries (Gunja et al., 2023).
Why So Expensive: A Multitude of Reasons
The United States spends more on healthcare than any other high-income nation because nearly every part of the system is structured to generate higher prices. One major reason is that, unlike many countries, the U.S. set national price controls for hospitals or drugs. Providers and pharmaceutical companies were allowed to charge market-driven rates, which encouraged innovation and helped firms recover high R&D costs (Papanicolas et al., 2018). But this approach also produces dramatic price variation and allows inflation to go largely unchecked.
A significant share of U.S. healthcare spending goes not to treatments, but to administration. Billing departments, insurance verification staff, coders, compliance officers, and claims processors create immense overhead. The Brookings Institution highlights that administrative spending in the U.S. far surpasses that of peer nations (Nunn et al., 2020). Gunja et al. (2023) similarly identify administrative expenditure as one of the top reasons costs continue to rise, with it reaching 8% of health spending, or over $800 per capita, compared to 1-3% in other countries.
Further contributing to overall spending, American doctors and specialists are among the highest-paid in the world. Papanicolas et al. (2018) note that generalist physician salaries in the U.S. averaged $218,173 compared to $86,607-$154,126 in other countries. In addition, expensive technologies–MRIs, robotic surgery, and specialized equipment–also raise costs dramatically and contribute significantly to the cost difference between the U.S. and peer nations (Papanicolas et al., 2018).
Physicians often order extra tests to protect themselves from malpractice claims, a practice called defensive medicine. This contributes billions in unnecessary spending. Mello et al. (2010) identify defensive medicine as costing approximately $45.6 billion annually, representing about 2.4% of total healthcare spending. When including all medical liability costs, the total reaches $55.6 billion annually (Commonwealth Fund, 2010).
Unlike other markets, healthcare prices are often hidden. Patients rarely know the cost, both before and after markup, of a procedure beforehand. This makes comparison between providers nearly impossible. The Center for American Progress reports that identical services can vary by thousands of dollars between hospitals, even within the same city (Calsyn, 2014). The Peterson-KFF Health System Tracker confirms that price transparency efforts continue to face significant compliance challenges (Peterson-KFF Health System Tracker, 2024). This opacity weakens competition and allows providers to set higher prices without fear of losing patients.
In addition, drug prices in the United States are notoriously high because pharmaceutical companies face fewer restrictions. Cubanski et al. (2023) explain that Medicare’s limited ability to negotiate drug prices kept prices elevated for millions of Americans prior to recent legislative changes. The Commonwealth Fund adds that the U.S. spends significantly more per capita on prescription drugs than peer nations (Commonwealth Fund, 2025). Pharmacy benefit managers (PBMs)–the intermediaries negotiating drug prices–add another layer of complexity without always delivering savings.
The U.S. has a high prevalence of chronic conditions requiring long-term care, with chronic diseases affecting approximately 60% of Americans. The Centers for Disease Control and Prevention reports that 90% of the nation’s $4.9 trillion in annual healthcare expenditures are for people with chronic and mental health conditions (Centers for Disease Control and Prevention, 2025). Meanwhile, increasing hospital consolidation: mergers that reduce competition and allow systems to raise prices unchecked. From 1998-2023, there were over 2,000 hospital mergers, and these mergers can increase prices by 5% or more (KFF, 2023).
Rising insurance premiums reflect these underlying costs. Yale Insights highlights that even insured Americans now struggle with deductibles and copays that make care inaccessible (Cooper, 2016). Employer-based coverage, which historically protected families, is increasingly expensive. According to the Commonwealth Fund, employers often pass rising costs on to workers through lower wages or higher premium contributions (Gunja et al., 2023). Underinsurance is now widespread. Many Americans technically “have insurance,” yet cannot afford to use it. For gig workers–part-time employees, and low-income households–access to affordable coverage remains limited.
Moving Forward
As the Center for American Progress explains, market power imbalances mean consumers often pay higher prices without receiving higher-quality care (Calsyn, 2014). The structure of the system itself creates inequity. The consequences are severe. High costs lead to delayed care, medical debt, and financial instability. At a macroeconomic level, rising healthcare spending burdens employers, suppresses wages, strains government budgets, and undermines U.S. economic competitiveness.
The American College of Surgeons warns that the U.S. healthcare system is already in crisis, facing unsustainable cost trajectories and worsening challenges to access (Elsey, 2025). Without reform, the combination of an aging population, expensive technology, and rising drug prices could push the system past a financial breaking point.
There is no single fix, but several reforms could reduce costs and improve the system. The Center for American Progress recommends requiring hospitals and providers to make consumer-facing prices public (Calsyn, 2014). Yale Insights argues for stronger antitrust enforcement to break up monopolistic provider systems (Cooper, 2016). Administrative simplification is another option: the Commonwealth Fund suggests streamlining billing systems and reducing paperwork (Gunja et al., 2023). Expanding value-based care models could also shift incentives toward quality rather than volume. Finally, greater investment in preventive care would help reduce the long-term burden of chronic diseases–a critical step toward sustainability.
Conclusion
The high cost of healthcare in the United States is not simply a policy failure; it is a structural one. For decades, fragmented insurance, opaque prices, weak competition, and misaligned incentives have shaped a system where patients pay more for less. These choices were not made with today’s challenges in mind, yet they define the lives–and finances–of millions of Americans. If the United States wants a healthcare system that is both humane and economically sustainable, it must confront the flaws built into its foundation. Reform is not only possible–it is necessary.
References
Calsyn, M. (2014, April 3). Shining light on health care prices. Center for American Progress. https://www.americanprogress.org/article/shining-light-on-health-care-prices/
Centers for Disease Control and Prevention. (2025, August 8). Fast facts: Health and economic costs of chronic conditions. https://www.cdc.gov/chronic-disease/data-research/facts-stats/index.html
Committee on the Costs of Medical Care. (1932). Medical care for the American people: The final report. University of Chicago Press.
Commonwealth Fund. (2010, September 7). Medical liability costs estimated at $55.6 billion annually. https://www.commonwealthfund.org/publications/newsletter-article/medical-liability-costs-estimated-556-billion-annually
Commonwealth Fund. (2025, May 15). Medicare drug price negotiations: All you need to know. https://www.commonwealthfund.org/publications/explainer/2025/may/medicare-drug-price-negotiations-all-you-need-know
Cooper, Z. (2016, February 12). Why is healthcare so expensive? Yale Insights. Yale School of Management. https://insights.som.yale.edu/insights/why-is-healthcare-so-expensive
Cubanski, J., Damico, A., & Neuman, T. (2023, August 9). FAQs about the Inflation Reduction Act’s Medicare drug price negotiation program. KFF. https://www.kff.org/medicare/faqs-about-the-inflation-reduction-acts-medicare-drug-price-negotiation-program/
Elsey, J. K. (2025, February). US healthcare system is in crisis. Bulletin of the American College of Surgeons, 110(2). https://www.facs.org/for-medical-professionals/news-publications/news-and-articles/bulletin/2025/february-2025-volume-110-issue-2/us-healthcare-system-is-in-crisis/
Gunja, M. Z., Gumas, E. D., & Williams II, R. D. (2023, October 4). High U.S. health care spending: Where is it all going? Commonwealth Fund. https://www.commonwealthfund.org/publications/issue-briefs/2023/oct/high-us-health-care-spending-where-is-it-all-going
KFF. (2023, August 9). Ten things to know about consolidation in health care provider markets. https://www.kff.org/health-costs/ten-things-to-know-about-consolidation-in-health-care-provider-markets/
Mello, M. M., Chandra, A., Gawande, A. A., & Studdert, D. M. (2010). National costs of the medical liability system. Health Affairs, 29(9), 1569-1577. https://doi.org/10.1377/hlthaff.2009.0807
Nunn, R., Parsons, J., & Shambaugh, J. (2020, March 10). A dozen facts about the economics of the U.S. health-care system. Brookings Institution. https://www.brookings.edu/articles/a-dozen-facts-about-the-economics-of-the-u-s-health-care-system/
Papanicolas, I., Woskie, L. R., & Jha, A. K. (2018). Health care spending in the United States and other high-income countries. JAMA, 319(10), 1024-1039. https://doi.org/10.1001/jama.2018.1150
Peterson-KFF Health System Tracker. (2024, July 8). Ongoing challenges with hospital price transparency. https://www.healthsystemtracker.org/brief/ongoing-challenges-with-hospital-price-transparency/